“心力衰竭国际学院”2016年第二期暨中国心力衰竭规范化诊疗促进项目(HFCOE)总结会在苏州隆重举办

2016-07-18 MedSci MedSci原创

张健教授主持并致辞2016年7月9日-10日,中国医师协会心力衰竭专业委员会、国家心血管病中心、北京力生心血管健康基金会联合主办的“心力衰竭国际学院”2016年第二期会议在苏州中华园大酒店隆重举办,会议由中国医师协会心力衰竭专业委员会主任委员张健教授主持, 来自复旦大学中山医院潘柏申教授、中国医学科学院阜外医院黄晓红教授、苏州大学附属第一医院沈振亚教授、上海交通大学医学院附属瑞金医院张凤如教授、东


张健教授主持并致辞

2016年7月9日-10日,中国医师协会心力衰竭专业委员会、国家心血管病中心、北京力生心血管健康基金会联合主办的“心力衰竭国际学院”2016年第二期会议在苏州中华园大酒店隆重举办,会议由中国医师协会心力衰竭专业委员会主任委员张健教授主持, 来自复旦大学中山医院潘柏申教授、中国医学科学院阜外医院黄晓红教授、苏州大学附属第一医院沈振亚教授、上海交通大学医学院附属瑞金医院张凤如教授、东南大学附属中大医院马根山教授、上海第十人民医院陈维教授、中国医学科学院阜外医院张宇辉教授、南京医科大学第一附属医院周蕾教授、上海中医药大学附属曙光医院王肖龙教授、上海第十人民医院徐大春教授、南京鼓楼医院王涟教授上台授课,多名青年才俊进行了典型病例分享,以及来自全国各地的200多位医生参与了此次盛会。


部分专家、学员合影


部分专家合影

大会中,张健教授、张宇辉教授对“中国心力衰竭规范化诊疗促进项目(HFCOE)”(由阿斯利康公司支持)两年来的工作以及取得的成果进行了总结:

1、 全国范围建立10家规范化诊疗示范中心;

2、 辐射100多家卫星医院

3、 进行了社区人群中心力衰竭及高危患者大规模调查

4、 发布中国心衰患者注册登记研究成果

5、 推动并设立了“全国心力衰竭日”,并在全国范围举办心衰日活动

6、 心力衰竭基层防控---内蒙古模式初步展开

7、 心力衰竭专业学术(网络)平台的建立

张健教授及专家组成员、企业代表(阿斯利康公司等)均表示会继续推动中国心力衰竭规范化诊疗促进项目(HFCOE)的下阶段工作,为中国心衰防治做出最大努力。


会议现场照片


会议现场照片


会议现场照片

背景:

“心力衰竭国际学院”于2016年3月12日由中国医师协会、中国医师协会心力衰竭专业委员会、国家心血管中心发起并在京成立。“心力衰竭国际学院”致力于在全国范围内广泛开展临床医生教育项目,进一步建立健全心衰系统化培训体系和机制,进一步提高我国临床医生心衰规范化防治水平,从而改善我国心衰整体防治局面。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1721625, encodeId=23811e21625f6, content=<a href='/topic/show?id=f66c90645be' target=_blank style='color:#2F92EE;'>#规范化诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90645, encryptionId=f66c90645be, topicName=规范化诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272333051942, createdName=chenshujs, createdTime=Thu Mar 09 09:19:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135128, encodeId=3b3b135128b5, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:23:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691325, encodeId=72e41691325c4, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Sat Mar 11 02:19:00 CST 2017, time=2017-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93733, encodeId=13fd93e331c, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Tue Jul 19 20:51:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93366, encodeId=c3eb93366f0, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Jul 18 19:29:00 CST 2016, time=2016-07-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1721625, encodeId=23811e21625f6, content=<a href='/topic/show?id=f66c90645be' target=_blank style='color:#2F92EE;'>#规范化诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90645, encryptionId=f66c90645be, topicName=规范化诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272333051942, createdName=chenshujs, createdTime=Thu Mar 09 09:19:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135128, encodeId=3b3b135128b5, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:23:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691325, encodeId=72e41691325c4, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Sat Mar 11 02:19:00 CST 2017, time=2017-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93733, encodeId=13fd93e331c, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Tue Jul 19 20:51:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93366, encodeId=c3eb93366f0, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Jul 18 19:29:00 CST 2016, time=2016-07-18, status=1, ipAttribution=)]
    2016-09-25 1e10c84am36(暂无匿称)

    文章很好值得关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1721625, encodeId=23811e21625f6, content=<a href='/topic/show?id=f66c90645be' target=_blank style='color:#2F92EE;'>#规范化诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90645, encryptionId=f66c90645be, topicName=规范化诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272333051942, createdName=chenshujs, createdTime=Thu Mar 09 09:19:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135128, encodeId=3b3b135128b5, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:23:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691325, encodeId=72e41691325c4, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Sat Mar 11 02:19:00 CST 2017, time=2017-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93733, encodeId=13fd93e331c, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Tue Jul 19 20:51:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93366, encodeId=c3eb93366f0, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Jul 18 19:29:00 CST 2016, time=2016-07-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1721625, encodeId=23811e21625f6, content=<a href='/topic/show?id=f66c90645be' target=_blank style='color:#2F92EE;'>#规范化诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90645, encryptionId=f66c90645be, topicName=规范化诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272333051942, createdName=chenshujs, createdTime=Thu Mar 09 09:19:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135128, encodeId=3b3b135128b5, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:23:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691325, encodeId=72e41691325c4, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Sat Mar 11 02:19:00 CST 2017, time=2017-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93733, encodeId=13fd93e331c, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Tue Jul 19 20:51:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93366, encodeId=c3eb93366f0, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Jul 18 19:29:00 CST 2016, time=2016-07-18, status=1, ipAttribution=)]
    2016-07-19 午夜星河

    应该好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1721625, encodeId=23811e21625f6, content=<a href='/topic/show?id=f66c90645be' target=_blank style='color:#2F92EE;'>#规范化诊疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90645, encryptionId=f66c90645be, topicName=规范化诊疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=272333051942, createdName=chenshujs, createdTime=Thu Mar 09 09:19:00 CST 2017, time=2017-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=135128, encodeId=3b3b135128b5, content=文章很好值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 25 17:23:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1691325, encodeId=72e41691325c4, content=<a href='/topic/show?id=a6cc90633f2' target=_blank style='color:#2F92EE;'>#规范化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90633, encryptionId=a6cc90633f2, topicName=规范化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=869a29217831, createdName=windight, createdTime=Sat Mar 11 02:19:00 CST 2017, time=2017-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93733, encodeId=13fd93e331c, content=应该好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Tue Jul 19 20:51:00 CST 2016, time=2016-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93366, encodeId=c3eb93366f0, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Mon Jul 18 19:29:00 CST 2016, time=2016-07-18, status=1, ipAttribution=)]
    2016-07-18 doctorJiangchao

    好文章

    0

相关资讯

12th AAHFN:植入式无线装置对心衰患者好处多多

根据第十二届美国心脏衰竭护士协会的年度会议(12th AAHFN)上呈现的研究结果,针对NYHA III级的一年内因心衰(HF)住院的HF患者,使用植入式无线装置测量肺动脉压和心率,可显著降低患者在急诊停留的平均天数。 兰开斯特一般健康心脏组织的Lisa D. Rathman及其同事对21名患者的动态血流动力学监测数据进行了回顾。这些患者军事因为HF住院,使用CardioMEMS (St.

盘点:甜菜根汁对心血管健康有那么多好处,还不赶紧喝起来?

上图就是甜菜根,其表面光滑,肉质通常呈深红色或白色,其叶子和根部均可食用。甜菜根可以凉拌生吃,可以熬汤,还可以榨汁,也就是甜菜根汁,能最大限度获取甜菜根中的营养。为什么说甜菜根是心血管健康的圣品呢?请和小编一起来学习。1-ESH 2016:甜菜根汁对动脉功能和心脏结构的影响2016年欧洲高血压学会(ESH)年会上,来自伦敦大学国王学院的两项研究表明:治疗24周后,25-50 mg/天 螺内酯组 v

BMJ:糖尿病药物的使用可降低心血管疾病和心衰的发生风险及全因死亡率

本研究旨在评估2型糖尿病患者使用不同的糖尿病药物的心血管疾病、心脏衰竭及全因死亡率发生风险之间的关联,特别是较新的药物,包括列汀类药物和噻唑烷二酮类药物(格列酮类)。采用开放性队列研究设计,共纳入469688名2型糖尿病患者,年龄在25-84岁之间。所纳入研究的糖尿病药物包括二甲双胍、列汀类、磺脲类药物,格列酮类,胰岛素等,单独使用和联合应用。主要研究结果为患者的初级保健、死亡或医院记录中心血管疾

JACC:心肌梗死后心衰的患者,癌症风险更高

根据美国心脏病学院杂志发表的研究数据显示,心肌梗死后发生心衰的患者,患癌症的风险增加了。梅奥医疗保健科的Veronique L. Roger博士和同事分析了1081例明尼苏达心肌梗死患者的数据,在平均4.9年时间里随访了5327人年。在研究期间,228例(21%)心肌梗死患者发展为心衰,98例发生癌症,不包括非黑色素瘤皮肤癌。中位数诊断为心衰的时间为3天;心衰患者的癌症发病率密度率33.7/100

JACC:Sacubitril/Valsartan可降低心衰患者30天再入院率

近期有研究表明,对于射血分数下降的心衰(HF)患者,使用sacubitril/缬沙坦 (Entresto, Novartis)相比依那普利,可降低20%的复合终点(心血管死亡或心衰住院)。ENTRESTO是sacubitril和缬沙坦复方药,其中sacubitril是脑啡肽酶[neprilysin]抑制剂,缬沙坦则是血管紧张素II受体阻断剂。来自布莱根妇女医院的Akshay S. Desai博士和

JAMA:依他普仑并不能有效治疗伴有抑郁的慢性心力衰竭患者

心力衰竭患者常发生抑郁症,且抑郁常与不良的临床结果相关。而是用选择性5-羟色胺再摄取抑制剂治疗这些患者的长期疗效和安全性尚未可知。本研究旨在确定是用依他普仑治疗慢性收缩性心力衰竭和抑郁症患者24个月后对其死亡率,发病率及情绪的改善情况。采用双盲、安慰剂对照的随机临床试验设计,纳入德国的16个三级医疗中心。筛选了2009年3月至2014年月之间纽约心脏协会分类II-IV级心脏衰竭,左室射血分数降低(